© 2025 - 2026
The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma
Emerging CELMoD research at ASCO 2026 highlights novel therapeutic strategies for relapsed/refractory multiple myeloma, addressing evolving patient needs.